TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs1842076
log Bayes Factor = 11.8448
Chromosome 5   position 40,237,018  (GRCh37) Explore rs1842076 on Ensembl!
Variant rs1842076 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
D12.5 Sigmoid colon
1.000 0.000 0.000
D12 Benign neoplasm of colon, rectum, anus and anal canal
1.000 0.000 0.000
D12.2 Ascending colon
1.000 0.000 0.000
D12.3 Transverse colon
0.999 0.001 0.000
D12.4 Descending colon
0.996 0.004 0.000
D12.6 Colon, unspecified
0.968 0.032 0.000
D12.8 Rectum
0.936 0.064 0.000
D12.0 Caecum
0.915 0.085 0.000
C18 Malignant neoplasm of colon
0.893 0.107 0.000
C18.7 Sigmoid colon
0.887 0.113 0.000
C18.9 Colon, unspecified
0.887 0.113 0.000
C18.0 Caecum
0.839 0.161 0.000
D12.1 Appendix
0.818 0.182 0.000
C18.2 Ascending colon
0.813 0.187 0.000
C18.6 Descending colon
0.781 0.219 0.000
C18.8 Overlapping lesion of colon
0.729 0.271 0.000
C18.4 Transverse colon
0.695 0.305 0.000
K50 Crohn's disease [regional enteritis]
0.000 0.375 0.625
K50.1 Crohn's disease of large intestine
0.000 0.379 0.621
K50.9 Crohn's disease, unspecified
0.000 0.399 0.601
K50.0 Crohn's disease of small intestine
0.000 0.405 0.595
C18.1 Appendix
0.583 0.417 0.000
K50.8 Other Crohn's disease
0.000 0.428 0.572
C20 Malignant neoplasm of rectum
0.566 0.434 0.000
C15-C26 Malignant neoplasms of digestive organs
0.555 0.444 0.000
C26 Malignant neoplasm of other and ill-defined digestive organs
0.521 0.479 0.000
C26.0 Intestinal tract, part unspecified
0.503 0.497 0.000
K50-K52 Noninfective enteritis and colitis
0.000 0.586 0.414
C18.5 Splenic flexure
0.412 0.588 0.000
C26.8 Overlapping lesion of digestive system
0.374 0.626 0.000
C26.1 Spleen
0.374 0.626 0.000
K51 Ulcerative colitis
0.000 0.648 0.352
C25 Malignant neoplasm of pancreas
0.350 0.650 0.000
C21 Malignant neoplasm of anus and anal canal
0.347 0.652 0.000
C18.3 Hepatic flexure
0.345 0.655 0.000
C15 Malignant neoplasm of oesophagus
0.339 0.661 0.000
K52 Other non-infective gastro-enteritis and colitis
0.000 0.667 0.333
D12.9 Anus and anal canal
0.328 0.671 0.001
C26.9 Ill-defined sites within the digestive system
0.328 0.671 0.000
C17 Malignant neoplasm of small intestine
0.325 0.674 0.000
K52.1 Toxic gastro-enteritis and colitis
0.000 0.710 0.290
K52.8 Other specified non-infective gastro-enteritis and colitis
0.000 0.714 0.286
K51.9 Ulcerative colitis, unspecified
0.000 0.717 0.283
C24 Malignant neoplasm of other and unspecified parts of biliary tract
0.280 0.720 0.000
K51.2 Ulcerative (chronic) proctitis
0.000 0.722 0.278
C25.0 Head of pancreas
0.278 0.722 0.000
K51.1 Ulcerative (chronic) ileocolitis
0.000 0.722 0.278
C21.8 Overlapping lesion of rectum, anus and anal canal
0.278 0.722 0.000
K51.3 Ulcerative (chronic) rectosigmoiditis
0.000 0.731 0.269
C15.3 Upper third of oesophagus
0.267 0.733 0.000
C25.1 Body of pancreas
0.262 0.738 0.000
C15.5 Lower third of oesophagus
0.261 0.739 0.000
K51.5 Mucosal proctocolitis
0.000 0.740 0.260
C25.8 Overlapping lesion of pancreas
0.260 0.740 0.000
K52.3 Indeterminate colitis
0.000 0.741 0.259
C25.4 Endocrine pancreas
0.257 0.742 0.000
C22 Malignant neoplasm of liver and intrahepatic bile ducts
0.036 0.749 0.215
C21.2 Cloacogenic zone
0.249 0.751 0.000
C15.1 Thoracic part of oesophagus
0.248 0.752 0.000
C25.3 Pancreatic duct
0.247 0.753 0.000
K51.8 Other ulcerative colitis
0.000 0.756 0.244
C15.0 Cervical part of oesophagus
0.244 0.756 0.000
C15.8 Overlapping lesion of oesophagus
0.243 0.757 0.000
C15.2 Abdominal part of oesophagus
0.243 0.757 0.000
C25.7 Other parts of pancreas
0.243 0.757 0.000
K52.0 Gastro-enteritis and colitis due to radiation
0.000 0.757 0.243
C17.0 Duodenum
0.239 0.760 0.000
K51.4 Pseudopolyposis of colon
0.000 0.760 0.240
K52.2 Allergic and dietetic gastro-enteritis and colitis
0.000 0.764 0.236
C17.8 Overlapping lesion of small intestine
0.233 0.766 0.000
C17.3 Meckel's diverticulum
0.233 0.766 0.000
C15.4 Middle third of oesophagus
0.232 0.768 0.000
C25.2 Tail of pancreas
0.229 0.771 0.000
C17.9 Small intestine, unspecified
0.229 0.771 0.000
K51.0 Ulcerative (chronic) enterocolitis
0.000 0.775 0.225
C21.1 Anal canal
0.224 0.776 0.000
C22.9 Liver, unspecified
0.006 0.780 0.214
C22.0 Liver cell carcinoma
0.006 0.783 0.211
C17.2 Ileum
0.214 0.785 0.000
C22.1 Intrahepatic bile duct carcinoma
0.007 0.788 0.205
C23 Malignant neoplasm of gallbladder
0.204 0.795 0.001
C24.8 Overlapping lesion of biliary tract
0.201 0.799 0.000
C17.1 Jejunum
0.186 0.814 0.001
C21.0 Anus, unspecified
0.180 0.820 0.000
C22.7 Other specified carcinomas of liver
0.026 0.820 0.154
C22.4 Other sarcomas of liver
0.026 0.820 0.154
C22.3 Angiosarcoma of liver
0.026 0.820 0.154
C22.2 Hepatoblastoma
0.026 0.820 0.154
D12.7 Rectosigmoid junction
0.178 0.821 0.001
C24.9 Biliary tract, unspecified
0.176 0.823 0.001
C24.0 Extrahepatic bile duct
0.174 0.825 0.000
C24.1 Ampulla of Vater
0.167 0.832 0.000
C19 Malignant neoplasm of rectosigmoid junction
0.167 0.833 0.000
C25.9 Pancreas, unspecified
0.158 0.842 0.000
C15.9 Oesophagus, unspecified
0.100 0.900 0.000
C16 Malignant neoplasm of stomach
0.080 0.920 0.001
T50.9 Other and unspecified drugs, medicaments and biological substances
0.063 0.937 0.000
C16.5 Lesser curvature of stomach, unspecified
0.061 0.939 0.000
C16.8 Overlapping lesion of stomach
0.057 0.942 0.001
C16.1 Fundus of stomach
0.056 0.943 0.000
C16.2 Body of stomach
0.056 0.944 0.000
C16.4 Pylorus
0.050 0.950 0.001
C16.6 Greater curvature of stomach, unspecified
0.048 0.951 0.001
C16.3 Pyloric antrum
0.046 0.954 0.001
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.046 0.954 0.000
F06.7 Mild cognitive disorder
0.044 0.956 0.000
F06 Other mental disorders due to brain damage and dysfunction and to physical disease
0.041 0.959 0.000
T50.1 Loop [high-ceiling] diuretics
0.036 0.964 0.000
F00-F09 Organic, including symptomatic, mental disorders
0.036 0.964 0.000
T50.8 Diagnostic agents
0.036 0.964 0.000
F01 Vascular dementia
0.035 0.965 0.000
F01.9 Vascular dementia, unspecified
0.035 0.965 0.000
T50.4 Drugs affecting uric acid metabolism
0.034 0.965 0.000
F06.9 Unspecified mental disorder due to brain damage and dysfunction and to physical disease
0.033 0.967 0.000
T50.7 Analeptics and opioid receptor antagonists
0.033 0.967 0.000
T50.6 Antidotes and chelating agents, not elsewhere classified
0.033 0.967 0.000
T50.5 Appetite depressants
0.033 0.967 0.000
T50.3 Electrolytic, caloric and water-balance agents
0.033 0.967 0.000
T50.0 Mineralocorticoids and their antagonists
0.033 0.967 0.000
Z08.0 Follow-up examination after surgery for malignant neoplasm
0.033 0.967 0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.032 0.968 0.000
M80.90 Unspecified osteoporosis with pathological fracture (Multiple sites)
0.031 0.969 0.000
F03 Unspecified dementia
0.031 0.969 0.000
F05 Delirium, not induced by alcohol and other psychoactive substances
0.030 0.970 0.000
F06.8 Other specified mental disorders due to brain damage and dysfunction and to physical disease
0.029 0.971 0.000
F06.6 Organic emotionally labile [asthenic] disorder
0.029 0.971 0.000
F06.5 Organic dissociative disorder
0.029 0.971 0.000
F06.4 Organic anxiety disorder
0.029 0.971 0.000
F06.3 Organic mood [affective] disorders
0.029 0.971 0.000
F06.2 Organic delusional [schizophrenia-like] disorder
0.029 0.971 0.000
F06.1 Organic catatonic disorder
0.029 0.971 0.000
F06.0 Organic hallucinosis
0.029 0.971 0.000
F00 Dementia in Alzheimer's disease
0.029 0.971 0.000
C16.9 Stomach, unspecified
0.026 0.973 0.001
M80.9 Unspecified osteoporosis with pathological fracture
0.026 0.973 0.000
F09 Unspecified organic or symptomatic mental disorder
0.026 0.974 0.000
F04 Organic amnesic syndrome, not induced by alcohol and other psychoactive substances
0.026 0.974 0.000
F00.2 Dementia in Alzheimer's disease, atypical or mixed type
0.026 0.974 0.000
K35.9 Acute appendicitis, unspecified
0.026 0.974 0.000
F05.9 Delirium, unspecified
0.026 0.974 0.000
F01.8 Other vascular dementia
0.025 0.975 0.000
F01.3 Mixed cortical and subcortical vascular dementia
0.025 0.975 0.000
F01.2 Subcortical vascular dementia
0.025 0.975 0.000
F01.1 Multi-infarct dementia
0.025 0.975 0.000
F01.0 Vascular dementia of acute onset
0.025 0.975 0.000
F02 Dementia in other diseases classified elsewhere
0.025 0.975 0.000
C16.0 Cardia
0.023 0.976 0.001
M80.98 Unspecified osteoporosis with pathological fracture (Other)
0.023 0.977 0.000
F05.1 Delirium superimposed on dementia
0.023 0.977 0.000
F07 Personality and behavioural disorders due to brain disease, damage and dysfunction
0.021 0.978 0.000
T36-T50 Poisoning by drugs, medicaments and biological substances
0.022 0.978 0.000
K35 Acute appendicitis
0.021 0.979 0.000
F00.1 Dementia in Alzheimer's disease with late onset
0.021 0.979 0.000
M80.99 Unspecified osteoporosis with pathological fracture (Site unspecified)
0.021 0.979 0.000
F02.0 Dementia in Pick's disease
0.021 0.979 0.000
H52.1 Myopia
0.000 0.979 0.021
F05.0 Delirium not superimposed on dementia, so described
0.020 0.979 0.000
F05.8 Other delirium
0.020 0.980 0.000
F00.0 Dementia in Alzheimer's disease with early onset
0.020 0.980 0.000
K35.0 Acute appendicitis with generalised peritonitis
0.020 0.980 0.000
M80.97 Unspecified osteoporosis with pathological fracture (Ankle and foot)
0.019 0.981 0.000
M80.96 Unspecified osteoporosis with pathological fracture (Lower leg)
0.019 0.981 0.000
M80.95 Unspecified osteoporosis with pathological fracture (Pelvic region and thigh)
0.019 0.981 0.000
M80.94 Unspecified osteoporosis with pathological fracture (Hand)
0.019 0.981 0.000
M80.93 Unspecified osteoporosis with pathological fracture (Forearm)
0.019 0.981 0.000
M80.92 Unspecified osteoporosis with pathological fracture (Upper arm)
0.019 0.981 0.000
M80.91 Unspecified osteoporosis with pathological fracture (Shoulder region)
0.019 0.981 0.000
K35.2 Acute appendicitis with generalized peritonitis
0.019 0.981 0.000
H52 Disorders of refraction and accommodation
0.000 0.981 0.019
T36 Poisoning by systemic antibiotics
0.018 0.981 0.000
F02.4 Dementia in human immunodeficiency virus [HIV] disease
0.018 0.982 0.000
F02.2 Dementia in Huntington's disease
0.018 0.982 0.000
F02.1 Dementia in Creutzfeldt-Jakob disease
0.018 0.982 0.000
K35.8 Acute appendicitis, other and unspecified
0.018 0.982 0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.018 0.982 0.000
F00.9 Dementia in Alzheimer's disease, unspecified
0.018 0.982 0.000
Z96.1 Presence of intraocular lens
0.000 0.982 0.018
H52.2 Astigmatism
0.000 0.982 0.018
F02.3 Dementia in Parkinson's disease
0.017 0.983 0.000
M80 Osteoporosis with pathological fracture
0.017 0.983 0.000
H52.3 Anisometropia and aniseikonia
0.000 0.983 0.017
T46 Poisoning by agents primarily affecting the cardiovascular system
0.017 0.983 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.017 0.983 0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.016 0.983 0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.016 0.983 0.000
T36.0 Penicillins
0.016 0.984 0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.016 0.984 0.000
F07.9 Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction
0.016 0.984 0.000
F07.8 Other organic personality and behavioural disorders due to brain disease, damage and dysfunction
0.016 0.984 0.000
F07.1 Postencephalitic syndrome
0.016 0.984 0.000
F07.0 Organic personality disorder
0.016 0.984 0.000
T41 Poisoning by anaesthetics and therapeutic gases
0.016 0.984 0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.016 0.984 0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.015 0.985 0.000
M80.1 Postoophorectomy osteoporosis with pathological fracture
0.015 0.985 0.000
F02.8 Dementia in other specified diseases classified elsewhere
0.015 0.985 0.000
T48.6 Antiasthmatics, not elsewhere classified
0.015 0.985 0.000
K35.3 Acute appendicitis with localized peritonitis
0.015 0.985 0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.014 0.985 0.000
T48.5 Anti-common-cold drugs
0.014 0.985 0.000
M80.10 Postoophorectomy osteoporosis with pathological fracture (Multiple sites)
0.014 0.986 0.000
T45.0 Antiallergic and antiemetic drugs
0.014 0.986 0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.014 0.986 0.000
H52.7 Disorder of refraction, unspecified
0.000 0.986 0.014
H52.4 Presbyopia
0.000 0.986 0.014
T42.4 Benzodiazepines
0.014 0.986 0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.014 0.986 0.000
T45.2 Vitamins, not elsewhere classified
0.014 0.986 0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.014 0.986 0.000
H52.6 Other disorders of refraction
0.000 0.986 0.013
H52.5 Disorders of accommodation
0.000 0.986 0.013
T36.9 Systemic antibiotic, unspecified
0.013 0.986 0.000
T36.8 Other systemic antibiotics
0.013 0.986 0.000
T36.7 Antifungal antibiotics, systemically used
0.013 0.986 0.000
T36.6 Rifamycins
0.013 0.986 0.000
T36.5 Aminoglycosides
0.013 0.986 0.000
T36.4 Tetracyclines
0.013 0.986 0.000
T36.3 Macrolides
0.013 0.986 0.000
T36.2 Chloramphenicol group
0.013 0.986 0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.013 0.986 0.000
T37.2 Antimalarials and drugs acting on other blood protozoa
0.013 0.987 0.000
T43.4 Butyrophenone and thioxanthene neuroleptics
0.013 0.987 0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.013 0.987 0.000
T48.4 Expectorants
0.013 0.987 0.000
T48.3 Antitussives
0.013 0.987 0.000
T48.2 Other and unspecified agents primarily acting on muscles
0.013 0.987 0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.013 0.987 0.000
T48.0 Oxytocic drugs
0.013 0.987 0.000
T43.3 Phenothiazine antipsychotics and neuroleptics
0.013 0.987 0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.013 0.987 0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.013 0.987 0.000
T46.4 Angiotensin-converting-enzyme inhibitors
0.013 0.987 0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.013 0.987 0.000
T46.1 Calcium-channel blockers
0.013 0.987 0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.013 0.987 0.000
M80.0 Postmenopausal osteoporosis with pathological fracture
0.012 0.987 0.000
T43.6 Psychostimulants with abuse potential
0.012 0.987 0.000
M80.5 Idiopathic osteoporosis with pathological fracture
0.012 0.988 0.000
M80.4 Drug-induced osteoporosis with pathological fracture
0.012 0.988 0.000
M80.3 Postsurgical malabsorption osteoporosis with pathological fracture
0.012 0.988 0.000
M80.2 Osteoporosis of disuse with pathological fracture
0.012 0.988 0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.012 0.988 0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.012 0.988 0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.012 0.988 0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.012 0.988 0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.012 0.988 0.000
T44.1 Other parasympathomimetics [cholinergics]
0.012 0.988 0.000
T44.0 Anticholinesterase agents
0.012 0.988 0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.012 0.988 0.000
T46.8 Antivaricose drugs, including sclerosing agents
0.012 0.988 0.000
T46.7 Peripheral vasodilators
0.012 0.988 0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.012 0.988 0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.012 0.988 0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.012 0.988 0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.012 0.988 0.000
T37.5 Antiviral drugs
0.012 0.988 0.000
T37.4 Anthelminthics
0.012 0.988 0.000
T37.3 Other antiprotozoal drugs
0.012 0.988 0.000
T37.1 Antimycobacterial drugs
0.012 0.988 0.000
T37.0 Sulphonamides
0.012 0.988 0.000
T45.9 Primarily systemic and haematological agent, unspecified
0.012 0.988 0.000
T45.8 Other primarily systemic and haematological agents
0.012 0.988 0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.012 0.988 0.000
T45.6 Fibrinolysis-affecting drugs
0.012 0.988 0.000
T45.4 Iron and its compounds
0.012 0.988 0.000
T45.3 Enzymes, not elsewhere classified
0.012 0.988 0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.012 0.988 0.000
T42.3 Barbiturates
0.012 0.988 0.000
T49.9 Topical agent, unspecified
0.012 0.988 0.000
T49.8 Other topical agents
0.012 0.988 0.000
T49.7 Dental drugs, topically applied
0.012 0.988 0.000
T49.6 Otorhinolaryngological drugs and preparations
0.012 0.988 0.000
T49.5 Ophthalmological drugs and preparations
0.012 0.988 0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.012 0.988 0.000
T49.3 Emollients, demulcents and protectants
0.012 0.988 0.000
T49.2 Local astringents and local detergents
0.012 0.988 0.000
T49.1 Antipruritics
0.012 0.988 0.000
T37.8 Other specified systemic anti-infectives and antiparasitics
0.011 0.988 0.000
T41.5 Therapeutic gases
0.011 0.988 0.000
T41.4 Anaesthetic, unspecified
0.011 0.988 0.000
T41.3 Local anaesthetics
0.011 0.988 0.000
T41.2 Other and unspecified general anaesthetics
0.011 0.988 0.000
T41.1 Intravenous anaesthetics
0.011 0.988 0.000
T41.0 Inhaled anaesthetics
0.011 0.988 0.000
T43.9 Psychotropic drug, unspecified
0.011 0.988 0.000
T43.8 Other psychotropic drugs, not elsewhere classified
0.011 0.988 0.000
T46.3 Coronary vasodilators, not elsewhere classified
0.011 0.988 0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.011 0.988 0.000
T38.1 Thyroid hormones and substitutes
0.011 0.989 0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.011 0.989 0.000
M80.8 Other osteoporosis with pathological fracture
0.011 0.989 0.000
T42.5 Mixed antiepileptics, not elsewhere classified
0.011 0.989 0.000
T42.2 Succinimides and oxazolidinediones
0.011 0.989 0.000
F07.2 Postconcussional syndrome
0.011 0.989 0.001
M80.19 Postoophorectomy osteoporosis with pathological fracture (Site unspecified)
0.011 0.989 0.000
M80.18 Postoophorectomy osteoporosis with pathological fracture (Other)
0.011 0.989 0.000
M80.17 Postoophorectomy osteoporosis with pathological fracture (Ankle and foot)
0.011 0.989 0.000
M80.16 Postoophorectomy osteoporosis with pathological fracture (Lower leg)
0.011 0.989 0.000
M80.15 Postoophorectomy osteoporosis with pathological fracture (Pelvic region and thigh)
0.011 0.989 0.000
M80.14 Postoophorectomy osteoporosis with pathological fracture (Hand)
0.011 0.989 0.000
M80.13 Postoophorectomy osteoporosis with pathological fracture (Forearm)
0.011 0.989 0.000
M80.12 Postoophorectomy osteoporosis with pathological fracture (Upper arm)
0.011 0.989 0.000
M80.11 Postoophorectomy osteoporosis with pathological fracture (Shoulder region)
0.011 0.989 0.000
H52.0 Hypermetropia
0.000 0.989 0.011
K35.1 Acute appendicitis with peritoneal abscess
0.011 0.989 0.000
T42.0 Hydantoin derivatives
0.011 0.989 0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.011 0.989 0.000
T47.8 Other agents primarily affecting the gastro-intestinal system
0.011 0.989 0.000
T47.7 Emetics
0.011 0.989 0.000
T47.6 Antidiarrhoeal drugs
0.011 0.989 0.000
T47.5 Digestants
0.011 0.989 0.000
T47.4 Other laxatives
0.011 0.989 0.000
T47.3 Saline and osmotic laxatives
0.011 0.989 0.000
T47.2 Stimulant laxatives
0.011 0.989 0.000
T47.0 Histamine H(2)-receptor antagonists
0.011 0.989 0.000
T42.1 Iminostilbenes
0.010 0.989 0.000
T45.1 Antineoplastic and immunosuppressive drugs
0.010 0.990 0.000
T38.9 Other and unspecified hormone antagonists
0.010 0.990 0.000
T38.8 Other and unspecified hormones and their synthetic substitutes
0.010 0.990 0.000
T38.7 Androgens and anabolic congeners
0.010 0.990 0.000
T38.5 Other oestrogens and progestogens
0.010 0.990 0.000
T38.4 Oral contraceptives
0.010 0.990 0.000
T38.2 Antithyroid drugs
0.010 0.990 0.000
T38.0 Glucocorticoids and synthetic analogues
0.010 0.990 0.000
T39.4 Antirheumatics, not elsewhere classified
0.010 0.990 0.000
T39.2 Pyrazolone derivatives
0.010 0.990 0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.010 0.990 0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.009 0.990 0.000
T47.1 Other antacids and anti-gastric-secretion drugs
0.009 0.990 0.000
T46.5 Other antihypertensive drugs, not elsewhere classified
0.009 0.990 0.000
M80.00 Postmenopausal osteoporosis with pathological fracture (Multiple sites)
0.009 0.991 0.000
M80.50 Idiopathic osteoporosis with pathological fracture (Multiple sites)
0.009 0.991 0.000
M80.09 Postmenopausal osteoporosis with pathological fracture (Site unspecified)
0.009 0.991 0.000
M80.08 Postmenopausal osteoporosis with pathological fracture (Other)
0.009 0.991 0.000
M80.07 Postmenopausal osteoporosis with pathological fracture (Ankle and foot)
0.009 0.991 0.000
M80.06 Postmenopausal osteoporosis with pathological fracture (Lower leg)
0.009 0.991 0.000
M80.05 Postmenopausal osteoporosis with pathological fracture (Pelvic region and thigh)
0.009 0.991 0.000
M80.04 Postmenopausal osteoporosis with pathological fracture (Hand)
0.009 0.991 0.000
M80.03 Postmenopausal osteoporosis with pathological fracture (Forearm)
0.009 0.991 0.000
M80.02 Postmenopausal osteoporosis with pathological fracture (Upper arm)
0.009 0.991 0.000
M80.01 Postmenopausal osteoporosis with pathological fracture (Shoulder region)
0.009 0.991 0.000
T43.0 Tricyclic and tetracyclic antidepressants
0.009 0.991 0.000
T45.5 Anticoagulants
0.009 0.991 0.000
T78.2 Anaphylactic shock, unspecified
0.009 0.991 0.000
M80.59 Idiopathic osteoporosis with pathological fracture (Site unspecified)
0.009 0.991 0.000
M80.58 Idiopathic osteoporosis with pathological fracture (Other)
0.009 0.991 0.000
M80.57 Idiopathic osteoporosis with pathological fracture (Ankle and foot)
0.009 0.991 0.000
M80.56 Idiopathic osteoporosis with pathological fracture (Lower leg)
0.009 0.991 0.000
M80.55 Idiopathic osteoporosis with pathological fracture (Pelvic region and thigh)
0.009 0.991 0.000
M80.54 Idiopathic osteoporosis with pathological fracture (Hand)
0.009 0.991 0.000
M80.53 Idiopathic osteoporosis with pathological fracture (Forearm)
0.009 0.991 0.000
M80.51 Idiopathic osteoporosis with pathological fracture (Shoulder region)
0.009 0.991 0.000
M80.29 Osteoporosis of disuse with pathological fracture (Site unspecified)
0.009 0.991 0.000
M80.28 Osteoporosis of disuse with pathological fracture (Other)
0.009 0.991 0.000
M80.27 Osteoporosis of disuse with pathological fracture (Ankle and foot)
0.009 0.991 0.000
M80.26 Osteoporosis of disuse with pathological fracture (Lower leg)
0.009 0.991 0.000
M80.25 Osteoporosis of disuse with pathological fracture (Pelvic region and thigh)
0.009 0.991 0.000
M80.24 Osteoporosis of disuse with pathological fracture (Hand)
0.009 0.991 0.000
M80.23 Osteoporosis of disuse with pathological fracture (Forearm)
0.009 0.991 0.000
M80.22 Osteoporosis of disuse with pathological fracture (Upper arm)
0.009 0.991 0.000
M80.21 Osteoporosis of disuse with pathological fracture (Shoulder region)
0.009 0.991 0.000
M80.20 Osteoporosis of disuse with pathological fracture (Multiple sites)
0.009 0.991 0.000
M80.39 Postsurgical malabsorption osteoporosis with pathological fracture (Site unspecified)
0.009 0.991 0.000
M80.38 Postsurgical malabsorption osteoporosis with pathological fracture (Other)
0.009 0.991 0.000
M80.37 Postsurgical malabsorption osteoporosis with pathological fracture (Ankle and foot)
0.009 0.991 0.000
M80.36 Postsurgical malabsorption osteoporosis with pathological fracture (Lower leg)
0.009 0.991 0.000
M80.35 Postsurgical malabsorption osteoporosis with pathological fracture (Pelvic region and thigh)
0.009 0.991 0.000
M80.34 Postsurgical malabsorption osteoporosis with pathological fracture (Hand)
0.009 0.991 0.000
M80.33 Postsurgical malabsorption osteoporosis with pathological fracture (Forearm)
0.009 0.991 0.000
M80.32 Postsurgical malabsorption osteoporosis with pathological fracture (Upper arm)
0.009 0.991 0.000
M80.31 Postsurgical malabsorption osteoporosis with pathological fracture (Shoulder region)
0.009 0.991 0.000
M80.30 Postsurgical malabsorption osteoporosis with pathological fracture (Multiple sites)
0.009 0.991 0.000
M80.49 Drug-induced osteoporosis with pathological fracture (Site unspecified)
0.009 0.991 0.000
M80.48 Drug-induced osteoporosis with pathological fracture (Other)
0.009 0.991 0.000
M80.47 Drug-induced osteoporosis with pathological fracture (Ankle and foot)
0.009 0.991 0.000
M80.46 Drug-induced osteoporosis with pathological fracture (Lower leg)
0.009 0.991 0.000
M80.45 Drug-induced osteoporosis with pathological fracture (Pelvic region and thigh)
0.009 0.991 0.000
M80.44 Drug-induced osteoporosis with pathological fracture (Hand)
0.009 0.991 0.000
M80.43 Drug-induced osteoporosis with pathological fracture (Forearm)
0.009 0.991 0.000
M80.42 Drug-induced osteoporosis with pathological fracture (Upper arm)
0.009 0.991 0.000
M80.41 Drug-induced osteoporosis with pathological fracture (Shoulder region)
0.009 0.991 0.000
M80.40 Drug-induced osteoporosis with pathological fracture (Multiple sites)
0.009 0.991 0.000
T39.0 Salicylates
0.009 0.991 0.000
M80.52 Idiopathic osteoporosis with pathological fracture (Upper arm)
0.009 0.991 0.000
T43.5 Other and unspecified antipsychotics and neuroleptics
0.009 0.991 0.000
B00.9 Herpesviral infection, unspecified
0.009 0.991 0.000
M80.89 Other osteoporosis with pathological fracture (Site unspecified)
0.008 0.992 0.000
M80.87 Other osteoporosis with pathological fracture (Ankle and foot)
0.008 0.992 0.000
M80.86 Other osteoporosis with pathological fracture (Lower leg)
0.008 0.992 0.000
M80.85 Other osteoporosis with pathological fracture (Pelvic region and thigh)
0.008 0.992 0.000
M80.84 Other osteoporosis with pathological fracture (Hand)
0.008 0.992 0.000
M80.83 Other osteoporosis with pathological fracture (Forearm)
0.008 0.992 0.000
M80.82 Other osteoporosis with pathological fracture (Upper arm)
0.008 0.992 0.000
M80.81 Other osteoporosis with pathological fracture (Shoulder region)
0.008 0.992 0.000
M80.80 Other osteoporosis with pathological fracture (Multiple sites)
0.008 0.992 0.000
D61.9 Aplastic anaemia, unspecified
0.008 0.992 0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.008 0.992 0.000
Y52.3 Coronary vasodilators, not elsewhere classified
0.008 0.992 0.000
H43.1 Vitreous haemorrhage
0.000 0.992 0.008
D61 Other aplastic anaemias
0.008 0.992 0.000
B00 Herpesviral [herpes simplex] infections
0.008 0.992 0.000
C91.9 Lymphoid leukaemia, unspecified
0.007 0.992 0.000
M80.88 Other osteoporosis with pathological fracture (Other)
0.007 0.993 0.000
B00.5 Herpesviral ocular disease
0.007 0.993 0.000
C91 Lymphoid leukaemia
0.007 0.993 0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.007 0.993 0.000
D62 Acute posthaemorrhagic anaemia
0.007 0.993 0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.007 0.993 0.000
T43.2 Other and unspecified antidepressants
0.007 0.993 0.000
H49-H52 Disorders of ocular muscles, binocular movement, accommodation and refraction
0.000 0.993 0.007
S30.8 Other superficial injuries of abdomen, lower back and pelvis
0.000 0.993 0.007
C95.9 Leukaemia, unspecified
0.007 0.993 0.000
B00.4 Herpesviral encephalitis
0.007 0.993 0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.007 0.993 0.000
D60-D64 Aplastic and other anaemias
0.007 0.993 0.000
C95 Leukaemia of unspecified cell type
0.007 0.993 0.000
B00.3 Herpesviral meningitis
0.006 0.993 0.000
C88 Malignant immunoproliferative diseases
0.006 0.994 0.000
D61.1 Drug-induced aplastic anaemia
0.006 0.994 0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]
0.006 0.994 0.000
T40.5 Cocaine
0.006 0.994 0.000
D61.0 Constitutional aplastic anaemia
0.006 0.994 0.000
D63 Anaemia in chronic diseases classified elsewhere
0.006 0.994 0.000
D63.0 Anaemia in neoplastic disease
0.006 0.994 0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.006 0.994 0.000
T40.8 Lysergide [LSD]
0.006 0.994 0.000
T40.7 Cannabis (derivatives)
0.006 0.994 0.000
T40.3 Methadone
0.006 0.994 0.000
T40.1 Heroin
0.006 0.994 0.000
T40.0 Opium
0.006 0.994 0.000
C91.4 Hairy-cell leukaemia
0.006 0.994 0.000
C90 Multiple myeloma and malignant plasma cell neoplasms
0.006 0.994 0.000
T40.6 Other and unspecified narcotics
0.006 0.994 0.000
C91.1 Chronic lymphocytic leukaemia
0.006 0.994 0.000
M24.41 Recurrent dislocation and subluxation of joint (Shoulder region)
0.006 0.994 0.000
Y45.1 Salicylates
0.000 0.994 0.006
G51.9 Disorder of facial nerve, unspecified
0.006 0.994 0.000
D61.8 Other specified aplastic anaemias
0.006 0.994 0.000
D61.3 Idiopathic aplastic anaemia
0.006 0.994 0.000
D61.2 Aplastic anaemia due to other external agents
0.006 0.994 0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.005 0.994 0.000
B00.2 Herpesviral gingivostomatitis and pharyngotonsillitis
0.006 0.994 0.000
B00.8 Other forms of herpesviral infection
0.006 0.994 0.000
B00.7 Disseminated herpesviral disease
0.006 0.994 0.000
B00.0 Eczema herpeticum
0.006 0.994 0.000
C91.5 Adult T-cell leukaemia
0.006 0.994 0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.006 0.994 0.000
C91.8 Mature B-cell leukaemia Burkitt-type
0.005 0.994 0.000
C91.7 Other lymphoid leukaemia
0.005 0.994 0.000
C91.6 Prolymphocytic leukaemia of T-cell type
0.005 0.994 0.000
C91.3 Prolymphocytic leukaemia
0.005 0.994 0.000
C91.2 Subacute lymphocytic leukaemia
0.005 0.994 0.000
B00.1 Herpesviral vesicular dermatitis
0.005 0.994 0.000
C90.0 Multiple myeloma
0.005 0.994 0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.005 0.995 0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified
0.005 0.995 0.000
H49 Paralytic strabismus
0.000 0.995 0.005
D60 Acquired pure red cell aplasia [erythroblastopenia]
0.005 0.995 0.000
I21.1 Acute transmural myocardial infarction of inferior wall
0.000 0.995 0.005
C94 Other leukaemias of specified cell type
0.005 0.995 0.000
N39.3 Stress incontinence
0.000 0.995 0.005
C95.0 Acute leukaemia of unspecified cell type
0.005 0.995 0.000
I21.4 Acute subendocardial myocardial infarction
0.000 0.995 0.005
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.005 0.995 0.000
C86 Other specified types of T/NK-cell lymphoma
0.005 0.995 0.000
H51 Other disorders of binocular movement
0.000 0.995 0.005
C95.7 Other leukaemia of unspecified cell type
0.005 0.995 0.000
C95.2 Subacute leukaemia of unspecified cell type
0.005 0.995 0.000
C95.1 Chronic leukaemia of unspecified cell type
0.005 0.995 0.000
C91.0 Acute lymphoblastic leukaemia
0.005 0.995 0.000
T40.4 Other synthetic narcotics
0.005 0.995 0.000
C90.1 Plasma cell leukaemia
0.005 0.995 0.000
C88.0 Waldenstrom's macroglobulinaemia
0.005 0.995 0.000
I21.2 Acute transmural myocardial infarction of other sites
0.000 0.995 0.005
C88.9 Malignant immunoproliferative disease, unspecified
0.005 0.995 0.000
C88.7 Other malignant immunoproliferative diseases
0.005 0.995 0.000
C88.3 Immunoproliferative small intestinal disease
0.005 0.995 0.000
C88.2 Gamma heavy chain disease
0.005 0.995 0.000
C88.1 Alpha heavy chain disease
0.005 0.995 0.000
C83 Diffuse non-Hodgkin's lymphoma
0.005 0.995 0.000
H50 Other strabismus
0.000 0.995 0.005
C90.2 Plasmacytoma, extramedullary
0.005 0.995 0.000
D63.1 Anaemia in other chronic diseases classified elsewhere
0.005 0.995 0.000
M24.44 Recurrent dislocation and subluxation of joint (Hand)
0.005 0.995 0.000
C82.0 Small cleaved cell, follicular
0.005 0.995 0.000
C81 Hodgkin's disease
0.005 0.995 0.000
C93 Monocytic leukaemia
0.005 0.995 0.000
T84.6 Infection and inflammatory reaction due to internal fixation device [any site]
0.005 0.995 0.000
H50.1 Divergent concomitant strabismus
0.000 0.995 0.005
M24.4 Recurrent dislocation and subluxation of joint
0.005 0.995 0.000
C85.7 Other specified types of non-Hodgkin's lymphoma
0.004 0.995 0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs
0.000 0.995 0.005
C85.1 B-cell lymphoma, unspecified
0.004 0.995 0.000
H02.9 Disorder of eyelid, unspecified
0.000 0.995 0.005
Y45.5 4-Aminophenol derivatives
0.000 0.995 0.004
D60.9 Acquired pure red cell aplasia, unspecified
0.004 0.996 0.000
H50.8 Other specified strabismus
0.000 0.996 0.004
D63.8 Anaemia in other chronic diseases classified elsewhere
0.004 0.996 0.000
H49.1 Fourth [trochlear] nerve palsy
0.000 0.996 0.004
C83.8 Other types of diffuse non-Hodgkin's lymphoma
0.004 0.996 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.